In-Situ®, a world leader in water monitoring technology, received EPA approval for their RDO® methods, which are the only optical or luminescence-based DO methods to pass the rigorous ATP approval process.

Measured under the Clean Water Act will be Biochemical Oxygen Demand (BOD), Carbonaceous Biochemical Oxygen Demand (CBOD), and Dissolved Oxygen (DO)

Unlike other optical sensors, RDO Sensors stand up to harsh conditions, exhibit no sensor drift over extended periods, do not require hydration, and simplify deployment to a single step. In contrast to electrochemical sensors, the total cost of ownership is reduced due to the elimination of time-consuming maintenance steps and long-lasting sensor design.

“Our RDO technology provides our customers and partners with higher quality data and more robust performance at a significantly lower cost than currently available optical DO sensors,” stated Jon Firooz, Vice President of Marketing of In-Situ Inc.

”This superior optical DO technology will essentially render the membrane-based Clark cell electrode obsolete and is ideal for environmental water monitoring,” added Firooz.

Numerous Fortune 500 companies including Thermo Fisher Scientific, Rosemount Emerson, and others have embraced the advantages of the RDO technology for process, laboratory, and field applications through their OEM partnerships with In-Situ Inc.